A Focus on BTK Inhibitors in B-Cell Malignancies (Part 2 of 2): Implementing Digital Technology Tools Within Health-Systems to Improve Adherence and Patient Support

A Focus on BTK Inhibitors in B-Cell Malignancies (Part 2 of 2): Implementing Digital Technology Tools Within Health-Systems to Improve Adherence and Patient Support

Free On-Demand Accredited Podcast!

Click here to listen to Part 1 of this podcast series!

Faculty Presenter

Anthony J. Perissinotti, PharmD, BCOP
Hematology Clinical Pharmacist Specialist
Clinical Team Leader Hematology/Oncology
Adjunct Clinical Assistant Professor
University of Michigan - Michigan Medicine
Ann Arbor, Michigan
 
Program Description
Oral oncolytics have become integral to the treatment paradigm for B-cell malignancies, with Bruton’s tyrosine kinase (BTK) being central in several signaling pathways. Pharmacists may encounter patients receiving treatment for B-cell malignancies with oral BTK inhibitors and must proactively monitor patients. Available digital tools have expanded the pharmacist’s ability to monitor patients and optimize outcomes. This podcast will emphasize the role pharmacists play in improving adherence and patient management through the use of digital and telemedicine technologies in this patient population.

Target Audience:  Oncology and health-system pharmacists
Type of Activity: Knowledge
Release Date: May 27, 2021
Expiration Date: November 27, 2021
Time to Complete Activity: .75 hours
Fee: Free

Educational Objective
At the completion of this activity, participants will be able to:

• Define the pharmacist’s role in implementing digital and telemedicine technologies within the health system to improve adherence and provide remote patient monitoring and management

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.75 contact hours (0.075 CEU) under the ACPE universal activity number 0290-0000-21-235-H01-P. The activity is available for CE credit through November 27, 2021.


Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, listen to the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
 

---

Disclosures

Anthony J. Perissinotti, PharmD, BCOP, has no relevant financial relationships with commercial interests to disclose.

Pharmacy Times Continuing Education™ Planning Staff – Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Amy H. Seung, PharmD, BCOP, FHOPA; Crissy Wilson; Susan Pordon; Brianna Winters; and Chloe Taccetta have no relevant financial relationships with commercial interests to disclose.

An anonymous peer reviewer is used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this CPE activity, please contact:
ceinfo@pharmacytimes.com
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms